glutathione syndrome - an overview Thiogenesis Therapeutics
Description
The risk of inadvertent intravenous injection is extremely low in these locations
Preclinical investigations have demonstrated its capacity to upregulate oxidative phosphorylation gene networks and promote a slow-twitch (Type I) muscle fiber phenotype, effectively mimicking aspects of endurance exercise at the molecular level
Further exploration of ATRX-related pathways may provide novel treatment strategies for ATRX-mutated GBMs, particularly through targeted approaches that disrupt ALT and DNA repair mechanisms
Experimental Dermatology, 25(8), 630635
